SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-001519
Filing Date
2024-01-03
Accepted
2024-01-03 16:26:00
Documents
14
Period of Report
2023-12-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d648217d8k.htm   iXBRL 8-K 43442
2 EX-99.1 d648217dex991.htm EX-99.1 18520
6 GRAPHIC g648217g0103223207656.jpg GRAPHIC 3812
  Complete submission text file 0001193125-24-001519.txt   199168

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fixx-20231229.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20231229_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20231229_pre.xml EX-101.PRE 10831
8 EXTRACTED XBRL INSTANCE DOCUMENT d648217d8k_htm.xml XML 3226
Mailing Address ONE PATRIOTS PARK BEDFORD MA 01730
Business Address ONE PATRIOTS PARK BEDFORD MA 01730 781-301-7277
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 24506913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)